Cargando…
Amylin Receptor: A Common Pathophysiological Target in Alzheimer’s Disease and Diabetes Mellitus
Amylin (islet amyloid polypeptide) and amyloid-beta (Aβ) protein, which are deposited within pancreatic islets of diabetics and brains of Alzheimer’s patients respectively, share many biophysical and physiological properties. Emerging evidence indicates that the amylin receptor is a putative target...
Autores principales: | Fu, Wen, Patel, Aarti, Jhamandas, Jack H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744041/ https://www.ncbi.nlm.nih.gov/pubmed/23966942 http://dx.doi.org/10.3389/fnagi.2013.00042 |
Ejemplares similares
-
Short amylin receptor antagonist peptides improve memory deficits in Alzheimer’s disease mouse model
por: Soudy, Rania, et al.
Publicado: (2019) -
Extracellular vesicles enriched with amylin receptor are cytoprotective against the Aß toxicity in vitro
por: Soudy, Rania, et al.
Publicado: (2022) -
Author Correction: Short amylin receptor antagonist peptides improve memory deficits in Alzheimer’s disease mouse model
por: Soudy, Rania, et al.
Publicado: (2022) -
Genetic Depletion of Amylin/Calcitonin Receptors Improves Memory and Learning in Transgenic Alzheimer’s Disease Mouse Models
por: Patel, Aarti, et al.
Publicado: (2021) -
Cyclic AC253, a novel amylin receptor antagonist, improves cognitive deficits in a mouse model of Alzheimer's disease
por: Soudy, Rania, et al.
Publicado: (2016)